CDR-Life develops novel tumor-targeted immunotherapies. A key part of this process is the advancement of therapeutic candidates from discovery to early clinical development by developing, implementing, and executing strategies to characterize pharmacodynamic properties across several drug development programs.
To expand the Hit characterization team within our Pharmacology group we are seeking a highly motivated and experienced:
Research Associate Hit characterization (80-100%)
Characterization of antibody hits to generate first-in-class immuno-oncology drugs
You will play an important role in the early characterization of antibody hits using various immunological and cell biological assays to support the lead selection process as part of CDR-Life’s pipeline of immunotherapies. You will work in a highly dynamic matrix environment in close collaboration with other members of the Pharmacology & Discovery group to drive scientific research and innovation.
We are looking forward to receiving your application under email@example.com.
Wagistrasse 27, Schlieren, Switzerland